
Christopher R. Flowers, MD, MS, discusses what the current treatment landscape of follicular lymphoma looks like.

Christopher R. Flowers, MD, MS, discusses what the current treatment landscape of follicular lymphoma looks like.

A significant proportion of patients worldwide live disease-free for a decade or longer following first-line therapy, with various approaches suggesting that there may be pathways to develop approaches for a cure for at least a subset of patients

Christopher R. Flowers, MD, discusses the current therapies used for patients with relapsed/refractory diffuse large B-cell lymphoma and goes into specifics of the L-MIND trial after the long-term follow-up.









Christopher Flowers, MD, describes the management of an elderly patient with relapsed follicular lymphoma using newer novel therapy.

Published: June 19th 2020 | Updated:

Published: June 19th 2020 | Updated:

Published: June 19th 2020 | Updated:

Published: June 19th 2020 | Updated:

Published: June 19th 2020 | Updated:

Published: June 19th 2020 | Updated: